Trusted local news leader for Prescott area communities since 1882
Sat, July 20

In kickback scheme case involving fentanyl, former Arizona CEO to plead guilty

A box of the fentanyl-based drug Subsys in an undated photograph. (U.S. Attorney's Office for the Southern District of Alabama/Courtesy)

A box of the fentanyl-based drug Subsys in an undated photograph. (U.S. Attorney's Office for the Southern District of Alabama/Courtesy)

BOSTON — The former CEO of a company that produces a highly addictive fentanyl spray has agreed to plead guilty to participating in a scheme to pay kickbacks to doctors to boost prescriptions of the drug.

Former Insys Therapeutics CEO Michael Babich's guilty plea agreement was revealed by prosecutors in court documents filed this week.

Babich was among several executives of the Arizona-based company charged in the closely-watched case scheduled to go to trial next month. Insys founder John Kapoor and several others have pleaded not guilty.

They're charged with bribing doctors into prescribing large amounts of the powerful medication meant for cancer patients with severe pain.

Another Insys executive, Alec Burlakoff, pleaded guilty last month and is cooperating with prosecutors.

An email was sent to Babich's attorneys on Thursday.

Contact

This Week's Circulars

To view money-saving ads...